GlaxoSmithKline said to eye sale of $3.9b stake in India's HUL

GlaxoSmithKline said to eye sale of $3.9b stake in India's HUL

FILE PHOTO: The GlaxoSmithKline (GSK) logo on top of GSK Asia House is seen through vertical louvres in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera

GlaxoSmithKline Plc (GSK) will soon begin selling its stake in Hindustan Unilever Ltd (HUL) estimated to be worth almost ₹29,850 crore ($3.9 billion), a person aware of the development said. GSK received the shares earlier this month in return for the sale of its Indian consumer business to HUL.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter